Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Genotype 1”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00926614
What this trial is testing

Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

Who this might be right for
Hepatitis c
Brooke Army Medical Center 20
Large-scale testing (Phase 3)Study completedNCT02032888
What this trial is testing

Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 238
Not applicableStudy completedNCT01342003
What this trial is testing

HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b

Who this might be right for
Chronic Hepatitis C
Azienda Ospedaliera San Camillo Forlanini 388
Testing effectiveness (Phase 2)Study completedNCT01183169
What this trial is testing

Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment

Who this might be right for
Hepatitis C
Debiopharm International SA 459
Testing effectiveness (Phase 2)Study completedNCT00423670
What this trial is testing

Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 765
Testing effectiveness (Phase 2)Study completedNCT00851890
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Virus Infection
AbbVie (prior sponsor, Abbott) 30
Testing effectiveness (Phase 2)Study completedNCT01132313
What this trial is testing

Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 488
Large-scale testing (Phase 3)Study completedNCT00624325
What this trial is testing

Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 30
Early research (Phase 1)Study completedNCT00971308
What this trial is testing

Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 37
Early research (Phase 1)Study completedNCT01181024
What this trial is testing

A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic, Healthy Volunteer
Hoffmann-La Roche 82
Not applicableStudy completedNCT02582671
What this trial is testing

The Effectiveness of ABT-450/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C -An Observational Study in Ireland

Who this might be right for
Chronic Hepatitis C
AbbVie 101
Early research (Phase 1)Ended earlyNCT01425190
What this trial is testing

Pharmacokinetics of Boceprevir in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P07614)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 16
Post-approval studies (Phase 4)Study completedNCT01447420
What this trial is testing

Sustained Virological Response in Relation to IL28-b Expression in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 129
Testing effectiveness (Phase 2)Study completedNCT00475176
What this trial is testing

S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Not applicableStudy completedNCT02508090
What this trial is testing

Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin

Who this might be right for
Chronic Hepatitis C
Hoffmann-La Roche 10
Large-scale testing (Phase 3)Study completedNCT01498068
What this trial is testing

Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C

Who this might be right for
Genotype 1 Chronic Hepatitis C
Janssen-Cilag International NV 36
Not applicableWithdrawnNCT00876174
What this trial is testing

Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of Nebraska
Testing effectiveness (Phase 2)Study completedNCT01749150
What this trial is testing

Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without Cirrhosis

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 61
Large-scale testing (Phase 3)Ended earlyNCT01446250
What this trial is testing

Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C
Debiopharm International SA 8
Not applicableWithdrawnNCT02070107
What this trial is testing

Technology-Based Application To Improve The Triple Therapy Adherence Rate In Subjects With Hepatitis C Infection

Who this might be right for
Hepatitis C
University of Louisville
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation